Benztropine
Generic name: Pronounced as (benz' troe peen)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 07/15/2018
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
Why is this medication prescribed?
Benztropine is used along with other medications to treat the symptoms of Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance) and tremors caused by other medical problems or medications. Benztropine is in a class of medications called anticholinergics. It works by blocking a certain natural substance (acetylcholine) to help to decrease symptoms in people with Parkinson's disease.
How should this medicine be used?
Benztropine comes as a tablet to take by mouth. It usually is taken at bedtime. It is usually taken once daily but may be taken up to four times a day depending on your symptoms. Take benztropine at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take benztropine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Your doctor may start with a small dose and increase it slowly after seeing your response to benztropine. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand.
Do not stop taking benztropine suddenly without talking with your doctor, especially if you are also taking other medications. Sudden stoppage can cause symptoms of Parkinson's disease to return.
Other uses for this medicine
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking benztropine,
-
tell your doctor and pharmacist if you are allergic to benztropine, any other medications, or any of the ingredients in the benztropine preparation. Ask your doctor or pharmacist or check the package label for a list of the ingredients.
-
tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: tricyclic antidepressants such as desipramine (Norpramin), clomipramine (Anafranil), imipramine (Tofranil), or trimipramine (Surmontil) or haloperidol (Haldol).
-
tell your doctor if you have or have ever had tardive dyskinesia (uncontrollable movement of the face, tongue, or other body parts); glaucoma; prostatic hypertrophy (BPH, enlargement of the prostate gland) or other problems with your urinary system; or heart or blood pressure problems.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking benztropine , call your doctor.
-
if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking benztropine.
-
you should know that this drug may make you drowsy. Do not drive a car or operate machinery until you know how this drug affects you.
-
remember that alcohol can add to the drowsiness caused by benztropine.
-
plan to avoid unnecessary or prolonged exposure to sunlight and to wear protective clothing, sunglasses, and sunscreen. Benztropine may make your skin sensitive to sunlight.
-
talk to your doctor about the risks and benefits of taking benztropine if you are 65 years of age or older. Older adults should not usually take benztropine because it is not as safe or effective as other medications that can be used to treat the same condition.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
-
Side effects from benztropine are common. Tell your doctor if any of these symptoms are severe or do not go away:
-
dry mouth
-
difficulty or pain when urinating
-
constipation
-
vomiting
-
nausea
-
loss of appetite
-
-
Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately:
-
rash
-
fast, irregular, or pounding heartbeat
-
fever
-
confusion
-
depression
-
delusions or hallucinations
-
vision changes
-
-
Benztropine may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include the following:
-
excitement
-
confusion
-
nervousness
-
seeing things that do not exist (hallucinating)
-
dizziness
-
muscle weakness
-
dry mouth
-
blurred vision
-
rapid or pounding heartbeat
-
upset stomach
-
vomiting
-
painful urination
-
difficulty swallowing
-
rash
-
headache
-
hot, dry, flushed skin
-
bloody vomit
-
seizure
-
coma
-
heat stroke
-
heartburn
-
constipation
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your response to benztropine.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Moxifloxacin | Moxifloxacin The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Moxifloxacin. |
Delavirdine | Delavirdine The metabolism of Benzatropine can be decreased when combined with Delavirdine. |
Nevirapine | Nevirapine The metabolism of Benzatropine can be decreased when combined with Nevirapine. |
Dolasetron | Dolasetron The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dolasetron. |
Anagrelide | Anagrelide The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Anagrelide. |
Bisacodyl | Bisacodyl The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Benzatropine. |
Cilostazol | Cilostazol The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Cilostazol. |
Diphenoxylate | Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Benzatropine. |
Erythromycin and Sulfisoxazole | Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Erythromycin. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Benzatropine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level. |
Fenofibrate | Fenofibrate Benzatropine may decrease the excretion rate of Fenofibrate which could result in a higher serum level. |
Guanfacine | Guanfacine Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Magnesium Hydroxide | Magnesium Hydroxide Benzatropine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level. |
Magnesium Oxide | Magnesium Oxide The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Benzatropine. |
Methylergonovine | Methylergonovine The risk or severity of adverse effects can be increased when Methylergometrine is combined with Benzatropine. |
Mycophenolate | Mycophenolate Benzatropine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level. |
Naratriptan | Naratriptan Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Olsalazine | Olsalazine Olsalazine may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Paregoric | Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Benzatropine. |
Penbutolol | Penbutolol The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Acebutolol. |
Pentazocine | Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Benzatropine. |
Polyethylene glycol-electrolyte solution (PEG-ES) | Polyethylene glycol-electrolyte solution (PEG-ES) The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Benzatropine. |
Potassium | Potassium Potassium may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy. |
Prednisone | Prednisone Benzatropine may decrease the excretion rate of Prednisone which could result in a higher serum level. |
Psyllium | Psyllium The therapeutic efficacy of Plantago seed can be decreased when used in combination with Benzatropine. |
Ranitidine | Ranitidine The metabolism of Benzatropine can be decreased when combined with Ranitidine. |
Reserpine | Reserpine Reserpine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Rizatriptan | Rizatriptan Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Rizatriptan. |
Sumatriptan | Sumatriptan Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Sumatriptan. |
Tacrolimus | Tacrolimus Tacrolimus may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Tizanidine | Tizanidine Tizanidine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Zolmitriptan | Zolmitriptan Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Ampicillin Injection | Ampicillin Injection Benzatropine may decrease the excretion rate of Ampicillin which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection Benzatropine may decrease the excretion rate of Doxycycline which could result in a higher serum level. |
Famotidine Injection | Famotidine Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Famotidine. |
Fluconazole Injection | Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Benzatropine. |
Foscarnet Injection | Foscarnet Injection Foscarnet may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Hydromorphone Injection | Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Benzatropine. |
Levofloxacin Injection | Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Levofloxacin. |
Meperidine Injection | Meperidine Injection The risk or severity of adverse effects can be increased when Benzatropine is combined with Meperidine. |
Metoclopramide Injection | Metoclopramide Injection The risk or severity of adverse effects can be increased when Metoclopramide is combined with Benzatropine. |
Metronidazole Injection | Metronidazole Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Metronidazole. |
Morphine Injection | Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Benzatropine. |
Pamidronate Injection | Pamidronate Injection Pamidronic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Vancomycin Injection | Vancomycin Injection Benzatropine may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Altretamine | Altretamine Amphetamine may decrease the sedative and stimulatory activities of Benzatropine. |
Cefuroxime | Cefuroxime Cefuroxime may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Cyclosporine | Cyclosporine The metabolism of Benzatropine can be decreased when combined with Cyclosporine. |
Ondansetron | Ondansetron The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ondansetron. |
Granisetron | Granisetron The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Granisetron. |
Torsemide | Torsemide Torasemide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy. |
Olanzapine | Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Benzatropine. |
Alosetron | Alosetron Alosetron may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Dofetilide | Dofetilide The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dofetilide. |
Entacapone | Entacapone Entacapone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Hydroxychloroquine | Hydroxychloroquine The metabolism of Benzatropine can be decreased when combined with Hydroxychloroquine. |
Meloxicam | Meloxicam Meloxicam may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Oxcarbazepine | Oxcarbazepine Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Pantoprazole | Pantoprazole Pantoprazole may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Temozolomide | Temozolomide Benzatropine may decrease the excretion rate of Temozolomide which could result in a higher serum level. |
Zaleplon | Zaleplon Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Anakinra | Anakinra The metabolism of Benzatropine can be increased when combined with Anakinra. |
Desloratadine | Desloratadine Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Desloratadine. |
Linezolid | Linezolid Linezolid may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Rivastigmine | Rivastigmine The therapeutic efficacy of Benzatropine can be decreased when used in combination with Rivastigmine. |
Trimipramine | Trimipramine The metabolism of Benzatropine can be decreased when combined with Trimipramine. |
Etanercept Injection | Etanercept Injection The metabolism of Benzatropine can be increased when combined with Etanercept. |
Glycopyrrolate | Glycopyrrolate The risk or severity of adverse effects can be increased when Benzatropine is combined with Glycopyrronium. |
Perindopril | Perindopril Benzatropine may decrease the excretion rate of Perindopril which could result in a higher serum level. |
Tenofovir | Tenofovir Tenofovir may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Epinephrine Injection | Epinephrine Injection The risk or severity of Tachycardia can be increased when Benzatropine is combined with Epinephrine. |
Eplerenone | Eplerenone Eplerenone may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy. |
Escitalopram | Escitalopram The serum concentration of Escitalopram can be increased when it is combined with Benzatropine. |
Zonisamide | Zonisamide Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Adalimumab Injection | Adalimumab Injection The metabolism of Benzatropine can be increased when combined with Adalimumab. |
Aripiprazole | Aripiprazole The risk or severity of adverse effects can be increased when Aripiprazole is combined with Benzatropine. |
Atomoxetine | Atomoxetine Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Atomoxetine. |
Dexmethylphenidate | Dexmethylphenidate The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Benzatropine. |
Atazanavir | Atazanavir Atazanavir may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Almotriptan | Almotriptan Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Eletriptan | Eletriptan Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Mefloquine | Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Benzatropine. |
Polyethylene Glycol 3350 | Polyethylene Glycol 3350 The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Benzatropine. |
Vardenafil | Vardenafil The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Vardenafil. |
Alfuzosin | Alfuzosin The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Alfuzosin. |
Emtricitabine | Emtricitabine Benzatropine may decrease the excretion rate of Emtricitabine which could result in a higher serum level. |
Memantine | Memantine The therapeutic efficacy of Benzatropine can be decreased when used in combination with Memantine. |
Tegaserod | Tegaserod The metabolism of Tegaserod can be decreased when combined with Benzatropine. |
Tadalafil | Tadalafil Benzatropine may decrease the excretion rate of Tadalafil which could result in a higher serum level. |
Frovatriptan | Frovatriptan Frovatriptan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Gemifloxacin | Gemifloxacin The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Gemifloxacin. |
Progesterone | Progesterone The metabolism of Progesterone can be decreased when combined with Benzatropine. |
Apomorphine Injection | Apomorphine Injection Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Infliximab Injection | Infliximab Injection The metabolism of Benzatropine can be increased when combined with Infliximab. |
Protriptyline | Protriptyline Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Duloxetine | Duloxetine The metabolism of Duloxetine can be decreased when combined with Benzatropine. |
Tinidazole | Tinidazole Benzatropine may decrease the excretion rate of Tinidazole which could result in a higher serum level. |
Trospium | Trospium The risk or severity of adverse effects can be increased when Trospium is combined with Benzatropine. |
Cefditoren | Cefditoren Benzatropine may decrease the excretion rate of Cefdinir which could result in a higher serum level. |
Cinacalcet | Cinacalcet The metabolism of Benzatropine can be decreased when combined with Cinacalcet. |
Cyanocobalamin Injection | Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Erlotinib | Erlotinib The metabolism of Erlotinib can be decreased when combined with Benzatropine. |
Eszopiclone | Eszopiclone Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Ganciclovir | Ganciclovir Benzatropine may decrease the excretion rate of Ganciclovir which could result in a higher serum level. |
Ribavirin | Ribavirin Benzatropine may decrease the excretion rate of Ribavirin which could result in a higher serum level. |
Solifenacin | Solifenacin The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Solifenacin. |
Valganciclovir | Valganciclovir Benzatropine may decrease the excretion rate of Valganciclovir which could result in a higher serum level. |
Voriconazole | Voriconazole The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Voriconazole. |
Adefovir | Adefovir Adefovir may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Dextroamphetamine | Dextroamphetamine Amphetamine may decrease the sedative and stimulatory activities of Benzatropine. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The metabolism of Benzatropine can be decreased when combined with Peginterferon alfa-2b. |
Pramlintide Injection | Pramlintide Injection The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Benzatropine. |
Sodium Oxybate | Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Ibandronate | Ibandronate The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ibandronate. |
Isocarboxazid | Isocarboxazid Isocarboxazid may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Ramelteon | Ramelteon Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Darifenacin | Darifenacin The metabolism of Benzatropine can be decreased when combined with Darifenacin. |
Fentanyl | Fentanyl The risk or severity of adverse effects can be increased when Benzatropine is combined with Fentanyl. |
Pregabalin | Pregabalin Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Phenylephrine | Phenylephrine The risk or severity of Tachycardia can be increased when Benzatropine is combined with Phenylephrine. |
Tipranavir | Tipranavir The metabolism of Benzatropine can be decreased when combined with Tipranavir. |
Felbamate | Felbamate Felbamate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Ranolazine | Ranolazine The serum concentration of Benzatropine can be increased when it is combined with Ranolazine. |
Abatacept Injection | Abatacept Injection The metabolism of Benzatropine can be increased when combined with Abatacept. |
Rasagiline | Rasagiline Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline. |
Imatinib | Imatinib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Imatinib. |
Sitagliptin | Sitagliptin Benzatropine may decrease the excretion rate of Sitagliptin which could result in a higher serum level. |
Varenicline | Varenicline Benzatropine may decrease the excretion rate of Varenicline which could result in a higher serum level. |
Gefitinib | Gefitinib The metabolism of Benzatropine can be decreased when combined with Gefitinib. |
Albuterol | Albuterol The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Salbutamol. |
Paliperidone | Paliperidone The risk or severity of adverse effects can be increased when Paliperidone is combined with Benzatropine. |
Bortezomib | Bortezomib The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Benzatropine. |
Clofarabine Injection | Clofarabine Injection Benzatropine may decrease the excretion rate of Clofarabine which could result in a higher serum level. |
Lubiprostone | Lubiprostone Benzatropine may decrease the excretion rate of Lubiprostone which could result in a higher serum level. |
Oxaliplatin Injection | Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Oxaliplatin. |
Posaconazole | Posaconazole The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Posaconazole. |
Primaquine | Primaquine The metabolism of Primaquine can be decreased when combined with Benzatropine. |
Pemetrexed Injection | Pemetrexed Injection Benzatropine may decrease the excretion rate of Pemetrexed which could result in a higher serum level. |
Dimenhydrinate | Dimenhydrinate The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dimenhydrinate. |
Lisdexamfetamine | Lisdexamfetamine Lisdexamfetamine may decrease the sedative and stimulatory activities of Benzatropine. |
Nabilone | Nabilone The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Nabilone. |
Vorinostat | Vorinostat The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Vorinostat. |
Sorafenib | Sorafenib The metabolism of Benzatropine can be decreased when combined with Sorafenib. |
Sunitinib | Sunitinib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Sunitinib. |
Dronabinol | Dronabinol The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Dronabinol. |
Lapatinib | Lapatinib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lapatinib. |
Levocetirizine | Levocetirizine Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Pegaptanib Injection | Pegaptanib Injection Benzatropine may decrease the excretion rate of Pegaptanib which could result in a higher serum level. |
Dasatinib | Dasatinib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dasatinib. |
Mexiletine | Mexiletine The metabolism of Mexiletine can be decreased when combined with Benzatropine. |
Azacitidine Injection | Azacitidine Injection Benzatropine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Paclitaxel (with polyoxyethylated castor oil) Injection | Paclitaxel (with polyoxyethylated castor oil) Injection The therapeutic efficacy of Castor oil can be decreased when used in combination with Benzatropine. |
Temsirolimus | Temsirolimus The metabolism of Benzatropine can be decreased when combined with Temsirolimus. |
Lenalidomide | Lenalidomide Benzatropine may decrease the excretion rate of Lenalidomide which could result in a higher serum level. |
Nilotinib | Nilotinib The metabolism of Nilotinib can be decreased when combined with Benzatropine. |
Toremifene | Toremifene The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Toremifene. |
Budesonide | Budesonide Benzatropine may decrease the excretion rate of Budesonide which could result in a higher serum level. |
Desmopressin | Desmopressin Desmopressin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Betaine | Betaine The therapeutic efficacy of Benzatropine can be decreased when used in combination with Glycine betaine. |
OnabotulinumtoxinA Injection | OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Benzatropine is combined with Botulinum toxin type A. |
RimabotulinumtoxinB Injection | RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Benzatropine is combined with Botulinum Toxin Type B. |
Doripenem Injection | Doripenem Injection Benzatropine may decrease the excretion rate of Doripenem which could result in a higher serum level. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Arsenic trioxide. |
Desvenlafaxine | Desvenlafaxine Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Desvenlafaxine. |
Cevimeline | Cevimeline Cevimeline may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Nebivolol | Nebivolol The metabolism of Nebivolol can be decreased when combined with Benzatropine. |
Flecainide | Flecainide The metabolism of Flecainide can be decreased when combined with Benzatropine. |
Certolizumab Injection | Certolizumab Injection The metabolism of Benzatropine can be increased when combined with Certolizumab pegol. |
Daptomycin Injection | Daptomycin Injection Daptomycin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Methylnaltrexone Injection | Methylnaltrexone Injection Benzatropine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. |
Rufinamide | Rufinamide Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Midazolam | Midazolam Midazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Naltrexone Injection | Naltrexone Injection The risk or severity of adverse effects can be increased when Benzatropine is combined with Naltrexone. |
Dexrazoxane Injection | Dexrazoxane Injection Benzatropine may decrease the excretion rate of Dexrazoxane which could result in a higher serum level. |
Milnacipran | Milnacipran Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Milnacipran. |
Plerixafor Injection | Plerixafor Injection Benzatropine may decrease the excretion rate of Plerixafor which could result in a higher serum level. |
Sodium Phosphate | Sodium Phosphate The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Benzatropine. |
Fesoterodine | Fesoterodine Benzatropine may decrease the excretion rate of Fesoterodine which could result in a higher serum level. |
Degarelix Injection | Degarelix Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Degarelix. |
Betaxolol | Betaxolol The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Betaxolol. |
Iloperidone | Iloperidone The risk or severity of adverse effects can be increased when Iloperidone is combined with Benzatropine. |
Prasugrel | Prasugrel Benzatropine may decrease the excretion rate of Prasugrel which could result in a higher serum level. |
Lacosamide | Lacosamide Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Everolimus | Everolimus The metabolism of Benzatropine can be decreased when combined with Everolimus. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy. |
Dronedarone | Dronedarone The metabolism of Dronedarone can be decreased when combined with Benzatropine. |
AbobotulinumtoxinA Injection | AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Benzatropine is combined with Botulinum toxin type A. |
Pralatrexate Injection | Pralatrexate Injection Benzatropine may decrease the excretion rate of Pralatrexate which could result in a higher serum level. |
Palonosetron Injection | Palonosetron Injection Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Palonosetron. |
Saxagliptin | Saxagliptin Benzatropine may decrease the excretion rate of Saxagliptin which could result in a higher serum level. |
Telavancin Injection | Telavancin Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Telavancin. |
Romidepsin Injection | Romidepsin Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Romidepsin. |
Tapentadol | Tapentadol The risk or severity of adverse effects can be increased when Tapentadol is combined with Benzatropine. |
Topotecan | Topotecan Benzatropine may decrease the excretion rate of Topotecan which could result in a higher serum level. |
Golimumab Injection | Golimumab Injection The metabolism of Benzatropine can be increased when combined with Golimumab. |
Pazopanib | Pazopanib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pazopanib. |
Asenapine | Asenapine The risk or severity of adverse effects can be increased when Asenapine is combined with Benzatropine. |
Vigabatrin | Vigabatrin Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Oxymorphone | Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Benzatropine. |
Tocilizumab Injection | Tocilizumab Injection The metabolism of Benzatropine can be increased when combined with Tocilizumab. |
Dalfampridine | Dalfampridine Benzatropine may decrease the excretion rate of Dalfampridine which could result in a higher serum level. |
Eribulin Injection | Eribulin Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Eribulin. |
IncobotulinumtoxinA Injection | IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Benzatropine is combined with Botulinum toxin type A. |
Ceftaroline Injection | Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Lurasidone | Lurasidone The risk or severity of adverse effects can be increased when Lurasidone is combined with Benzatropine. |
Acetaminophen Injection | Acetaminophen Injection Benzatropine may decrease the excretion rate of Acetaminophen which could result in a higher serum level. |
Vilazodone | Vilazodone The metabolism of Benzatropine can be decreased when combined with Vilazodone. |
Ipilimumab Injection | Ipilimumab Injection Benzatropine may decrease the excretion rate of Ipilimumab which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Terbutaline Injection | Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Benzatropine. |
Roflumilast | Roflumilast Benzatropine may decrease the excretion rate of Roflumilast which could result in a higher serum level. |
Rilpivirine | Rilpivirine The metabolism of Benzatropine can be decreased when combined with Rilpivirine. |
Abiraterone | Abiraterone The metabolism of Benzatropine can be decreased when combined with Abiraterone. |
Triptorelin Injection | Triptorelin Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Triptorelin. |
Rivaroxaban | Rivaroxaban Benzatropine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level. |
Ruxolitinib | Ruxolitinib Benzatropine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level. |
Vandetanib | Vandetanib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Vandetanib. |
Clobazam | Clobazam The metabolism of Clobazam can be decreased when combined with Benzatropine. |
Vemurafenib | Vemurafenib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Vemurafenib. |
Deferiprone | Deferiprone Benzatropine may decrease the excretion rate of Deferiprone which could result in a higher serum level. |
Crizotinib | Crizotinib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Crizotinib. |
Cabergoline | Cabergoline Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Naloxone Injection | Naloxone Injection Benzatropine may decrease the excretion rate of Naloxone which could result in a higher serum level. |
Fondaparinux Injection | Fondaparinux Injection Benzatropine may decrease the excretion rate of Fondaparinux which could result in a higher serum level. |
Ezogabine | Ezogabine Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Enzalutamide | Enzalutamide Benzatropine may decrease the excretion rate of Enzalutamide which could result in a higher serum level. |
Mirabegron | Mirabegron The risk or severity of urinary retention can be increased when Benzatropine is combined with Mirabegron. |
Linaclotide | Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Benzatropine. |
Teduglutide Injection | Teduglutide Injection Benzatropine may decrease the excretion rate of Teduglutide which could result in a higher serum level. |
Bedaquiline | Bedaquiline The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bedaquiline. |
Alogliptin | Alogliptin Benzatropine may decrease the excretion rate of Alogliptin which could result in a higher serum level. |
Ponatinib | Ponatinib The metabolism of Ponatinib can be decreased when combined with Benzatropine. |
Pomalidomide | Pomalidomide Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Canagliflozin | Canagliflozin Benzatropine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Methazolamide | Methazolamide Methazolamide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy. |
Dabrafenib | Dabrafenib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dabrafenib. |
Ospemifene | Ospemifene The metabolism of Benzatropine can be decreased when combined with Ospemifene. |
Trametinib | Trametinib Benzatropine may decrease the excretion rate of Trametinib which could result in a higher serum level. |
Levomilnacipran | Levomilnacipran Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Levomilnacipran. |
Ertapenem Injection | Ertapenem Injection Benzatropine may decrease the excretion rate of Ertapenem which could result in a higher serum level. |
Vortioxetine | Vortioxetine Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine. |
Perampanel | Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Ibrutinib | Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Benzatropine. |
Ketorolac Injection | Ketorolac Injection Ketorolac may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Sofosbuvir | Sofosbuvir Benzatropine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin Benzatropine may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Apremilast | Apremilast The metabolism of Benzatropine can be increased when combined with Apremilast. |
Droxidopa | Droxidopa Benzatropine may decrease the excretion rate of Droxidopa which could result in a higher serum level. |
Ceritinib | Ceritinib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ceritinib. |
Siltuximab Injection | Siltuximab Injection The metabolism of Benzatropine can be increased when combined with Siltuximab. |
Eslicarbazepine | Eslicarbazepine Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Testosterone Injection | Testosterone Injection Benzatropine may decrease the excretion rate of Testosterone which could result in a higher serum level. |
Oritavancin Injection | Oritavancin Injection The metabolism of Benzatropine can be decreased when combined with Oritavancin. |
Hydrocodone | Hydrocodone The risk or severity of adverse effects can be increased when Hydrocodone is combined with Benzatropine. |
Suvorexant | Suvorexant Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Edoxaban | Edoxaban Benzatropine may decrease the excretion rate of Edoxaban which could result in a higher serum level. |
Methamphetamine | Methamphetamine Metamfetamine may decrease the sedative and stimulatory activities of Benzatropine. |
Tasimelteon | Tasimelteon Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Secukinumab Injection | Secukinumab Injection The metabolism of Benzatropine can be increased when combined with Secukinumab. |
Risperidone Injection | Risperidone Injection The risk or severity of adverse effects can be increased when Risperidone is combined with Benzatropine. |
Lenvatinib | Lenvatinib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lenvatinib. |
Naloxegol | Naloxegol The metabolism of Benzatropine can be decreased when combined with Naloxegol. |
Panobinostat | Panobinostat The metabolism of Benzatropine can be decreased when combined with Panobinostat. |
Haloperidol Injection | Haloperidol Injection The risk or severity of adverse effects can be increased when Haloperidol is combined with Benzatropine. |
Ivabradine | Ivabradine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ivabradine. |
Amiloride | Amiloride Amiloride may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy. |
Macitentan | Macitentan Benzatropine may decrease the excretion rate of Macitentan which could result in a higher serum level. |
Flibanserin | Flibanserin Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Rolapitant | Rolapitant The metabolism of Benzatropine can be decreased when combined with Rolapitant. |
Brexpiprazole | Brexpiprazole The therapeutic efficacy of Benzatropine can be decreased when used in combination with Brexpiprazole. |
Ziprasidone Injection | Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Benzatropine. |
Cariprazine | Cariprazine The therapeutic efficacy of Benzatropine can be decreased when used in combination with Cariprazine. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Benzatropine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Eluxadoline | Eluxadoline The risk or severity of constipation can be increased when Benzatropine is combined with Eluxadoline. |
Trabectedin Injection | Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Benzatropine. |
Ixazomib | Ixazomib Benzatropine may decrease the excretion rate of Ixazomib which could result in a higher serum level. |
Lesinurad | Lesinurad Benzatropine may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Brivaracetam Injection | Brivaracetam Injection Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Cobicistat | Cobicistat The metabolism of Benzatropine can be decreased when combined with Cobicistat. |
Midodrine | Midodrine The risk or severity of Tachycardia can be increased when Midodrine is combined with Benzatropine. |
Pimavanserin | Pimavanserin The therapeutic efficacy of Benzatropine can be decreased when used in combination with Pimavanserin. |
Diphenhydramine Injection | Diphenhydramine Injection The metabolism of Benzatropine can be decreased when combined with Diphenhydramine. |
Furosemide Injection | Furosemide Injection Benzatropine may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy. |
Rucaparib | Rucaparib The metabolism of Benzatropine can be decreased when combined with Rucaparib. |
Lixisenatide Injection | Lixisenatide Injection Benzatropine may decrease the excretion rate of Lixisenatide which could result in a higher serum level. |
Ribociclib | Ribociclib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ribociclib. |
Doxepin (Insomnia) | Doxepin (Insomnia) Doxepin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Plecanatide | Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Benzatropine. |
Deutetrabenazine | Deutetrabenazine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Deutetrabenazine. |
Valbenazine | Valbenazine Benzatropine may decrease the excretion rate of Valbenazine which could result in a higher serum level. |
Safinamide | Safinamide The metabolism of Benzatropine can be decreased when combined with Safinamide. |
Naldemedine | Naldemedine Benzatropine may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Midostaurin | Midostaurin The metabolism of Benzatropine can be decreased when combined with Midostaurin. |
Enasidenib | Enasidenib The metabolism of Benzatropine can be decreased when combined with Enasidenib. |
Benznidazole | Benznidazole Benzatropine may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Delafloxacin | Delafloxacin The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Delafloxacin. |
Letermovir | Letermovir The metabolism of Letermovir can be decreased when combined with Benzatropine. |
Tetrabenazine | Tetrabenazine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Tetrabenazine. |
Ertugliflozin | Ertugliflozin Ertugliflozin may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy. |
Buprenorphine Injection | Buprenorphine Injection The risk or severity of adverse effects can be increased when Buprenorphine is combined with Benzatropine. |
Apalutamide | Apalutamide Benzatropine may decrease the excretion rate of Apalutamide which could result in a higher serum level. |
Baricitinib | Baricitinib Benzatropine may decrease the excretion rate of Baricitinib which could result in a higher serum level. |
Lofexidine | Lofexidine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lofexidine. |
Plazomicin Injection | Plazomicin Injection Benzatropine may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Eliglustat | Eliglustat The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Eliglustat. |
Encorafenib | Encorafenib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Encorafenib. |
Ivosidenib | Ivosidenib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ivosidenib. |
Elagolix | Elagolix The metabolism of Elagolix can be decreased when combined with Benzatropine. |
Tafenoquine | Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Benzatropine. |
Cannabidiol | Cannabidiol The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Cannabidiol. |
Dacomitinib | Dacomitinib The metabolism of Benzatropine can be decreased when combined with Dacomitinib. |
Stiripentol | Stiripentol The metabolism of Benzatropine can be decreased when combined with Stiripentol. |
Gilteritinib | Gilteritinib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Gilteritinib. |
Glasdegib | Glasdegib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Glasdegib. |
Rifamycin | Rifamycin The metabolism of Benzatropine can be decreased when combined with Rifamycin. |
Prucalopride | Prucalopride Benzatropine may decrease the excretion rate of Prucalopride which could result in a higher serum level. |
Magnesium Citrate | Magnesium Citrate The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Benzatropine. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The metabolism of Benzatropine can be increased when combined with Emapalumab. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Brexanolone Injection | Brexanolone Injection Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Solriamfetol | Solriamfetol The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Benzatropine. |
Triclabendazole | Triclabendazole The metabolism of Benzatropine can be decreased when combined with Triclabendazole. |
Entrectinib | Entrectinib The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Entrectinib. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be decreased when combined with Benzatropine. |
Pitolisant | Pitolisant The therapeutic efficacy of Pitolisant can be decreased when used in combination with Benzatropine. |
Fedratinib | Fedratinib The metabolism of Benzatropine can be decreased when combined with Fedratinib. |
Lefamulin | Lefamulin Lefamulin may increase the QTc-prolonging activities of Benzatropine. |
Phenytoin Injection | Phenytoin Injection Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Fosphenytoin Injection | Fosphenytoin Injection Fosphenytoin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Lumateperone | Lumateperone The risk or severity of adverse effects can be increased when Lumateperone is combined with Benzatropine. |
Lasmiditan | Lasmiditan Lasmiditan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Lemborexant | Lemborexant Lemborexant may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Daratumumab and Hyaluronidase-fihj Injection | Daratumumab and Hyaluronidase-fihj Injection The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Benzatropine. |
Fenfluramine | Fenfluramine The metabolism of Benzatropine can be decreased when combined with Fenfluramine. |
Fostemsavir | Fostemsavir The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Fostemsavir. |
Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection | Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Benzatropine. |
Octreotide | Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Benzatropine. |
Relugolix | Relugolix The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Relugolix. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy. |
Viloxazine | Viloxazine Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine. |
Tobramycin Injection | Tobramycin Injection Tobramycin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Theophylline | Theophylline The metabolism of Theophylline can be decreased when combined with Benzatropine. |
Fenoprofen | Fenoprofen Fenoprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Indomethacin | Indomethacin Indomethacin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Mefenamic Acid | Mefenamic Acid Mefenamic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Naproxen | Naproxen Naproxen may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Tolmetin | Tolmetin Tolmetin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Sulindac | Sulindac Sulindac may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Trazodone | Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Benzatropine. |
Isotretinoin | Isotretinoin Benzatropine may decrease the excretion rate of Isotretinoin which could result in a higher serum level. |
Sucralfate | Sucralfate Benzatropine may decrease the excretion rate of Sucralfate which could result in a higher serum level. |
Hydroxyurea | Hydroxyurea The metabolism of Benzatropine can be decreased when combined with Hydroxyurea. |
Floxuridine | Floxuridine Benzatropine may decrease the excretion rate of Floxuridine which could result in a higher serum level. |
Phenobarbital | Phenobarbital Phenobarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Metaxalone | Metaxalone Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Methotrexate Injection | Methotrexate Injection Methotrexate may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Levorphanol | Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Benzatropine. |
Primidone | Primidone Primidone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Methsuximide | Methsuximide Methsuximide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Diethylpropion | Diethylpropion Diethylpropion may decrease the sedative and stimulatory activities of Benzatropine. |
Chlorpromazine | Chlorpromazine The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Benzatropine. |
Diazepam | Diazepam Diazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Oxazepam | Oxazepam Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Flurazepam | Flurazepam Flurazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Clorazepate | Clorazepate Clorazepic acid may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Lorazepam | Lorazepam Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Carmustine | Carmustine Benzatropine may decrease the excretion rate of Carmustine which could result in a higher serum level. |
Amantadine | Amantadine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Amantadine. |
Codeine | Codeine The risk or severity of adverse effects can be increased when Benzatropine is combined with Codeine. |
Meprobamate | Meprobamate Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Chlordiazepoxide | Chlordiazepoxide Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Bromocriptine | Bromocriptine Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Metaproterenol | Metaproterenol The risk or severity of Tachycardia can be increased when Benzatropine is combined with Orciprenaline. |
Tranylcypromine | Tranylcypromine The metabolism of Benzatropine can be decreased when combined with Tranylcypromine. |
Phenelzine | Phenelzine The metabolism of Benzatropine can be decreased when combined with Phenelzine. |
Procarbazine | Procarbazine Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Ergoloid Mesylates | Ergoloid Mesylates Ergoloid mesylate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Tetracycline | Tetracycline Benzatropine may decrease the excretion rate of Tetracycline which could result in a higher serum level. |
Prochlorperazine | Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Benzatropine. |
Thioridazine | Thioridazine The risk or severity of adverse effects can be increased when Thioridazine is combined with Benzatropine. |
Trifluoperazine | Trifluoperazine The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Benzatropine. |
Bleomycin | Bleomycin Benzatropine may decrease the excretion rate of Bleomycin which could result in a higher serum level. |
Sulfadiazine | Sulfadiazine Benzatropine may decrease the excretion rate of Sulfadiazine which could result in a higher serum level. |
Oxycodone | Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Benzatropine. |
Methadone | Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Benzatropine. |
Oxybutynin | Oxybutynin The metabolism of Oxybutynin can be decreased when combined with Benzatropine. |
Maprotiline | Maprotiline Maprotiline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Ibuprofen | Ibuprofen Ibuprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Trihexyphenidyl | Trihexyphenidyl The risk or severity of adverse effects can be increased when Benzatropine is combined with Trihexyphenidyl. |
Orphenadrine | Orphenadrine The metabolism of Benzatropine can be decreased when combined with Orphenadrine. |
Perphenazine | Perphenazine The risk or severity of adverse effects can be increased when Perphenazine is combined with Benzatropine. |
Azathioprine | Azathioprine Benzatropine may decrease the excretion rate of Azathioprine which could result in a higher serum level. |
Fluphenazine | Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Benzatropine. |
Phentermine | Phentermine Phentermine may decrease the sedative and stimulatory activities of Benzatropine. |
Methylphenidate | Methylphenidate The risk or severity of adverse effects can be increased when Methylphenidate is combined with Benzatropine. |
Amoxapine | Amoxapine The risk or severity of adverse effects can be increased when Amoxapine is combined with Benzatropine. |
Sulfasalazine | Sulfasalazine Sulfasalazine may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Doxorubicin | Doxorubicin The metabolism of Benzatropine can be decreased when combined with Doxorubicin. |
Mechlorethamine | Mechlorethamine The therapeutic efficacy of Benzatropine can be decreased when used in combination with Mechlorethamine. |
Pyridostigmine | Pyridostigmine The therapeutic efficacy of Benzatropine can be decreased when used in combination with Pyridostigmine. |
Phenazopyridine | Phenazopyridine Phenazopyridine may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Carbamazepine | Carbamazepine Benzatropine may decrease the excretion rate of Carbamazepine which could result in a higher serum level. |
Molindone | Molindone The risk or severity of adverse effects can be increased when Molindone is combined with Benzatropine. |
Methyldopa | Methyldopa Benzatropine may decrease the excretion rate of Methyldopa which could result in a higher serum level. |
Clonidine | Clonidine The metabolism of Benzatropine can be decreased when combined with Clonidine. |
Hydralazine | Hydralazine Benzatropine may decrease the excretion rate of Hydralazine which could result in a higher serum level. |
Cimetidine | Cimetidine The metabolism of Cimetidine can be decreased when combined with Benzatropine. |
Gentamicin Injection | Gentamicin Injection Gentamicin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Warfarin | Warfarin Benzatropine may decrease the excretion rate of Warfarin which could result in a higher serum level. |
Clonazepam | Clonazepam Clonazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Loperamide | Loperamide The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Loperamide. |
Promethazine | Promethazine The risk or severity of adverse effects can be increased when Promethazine is combined with Benzatropine. |
Meclofenamate | Meclofenamate Meclofenamic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Nitrofurantoin | Nitrofurantoin Benzatropine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level. |
Digoxin | Digoxin Benzatropine may decrease the excretion rate of Digoxin which could result in a higher serum level. |
Loxapine | Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Benzatropine. |
Chloroquine | Chloroquine The metabolism of Chloroquine can be decreased when combined with Benzatropine. |
Quinine | Quinine The metabolism of Quinine can be decreased when combined with Benzatropine. |
Ethosuximide | Ethosuximide Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Triamterene | Triamterene Triamterene may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Lactulose | Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Benzatropine. |
Chlorothiazide | Chlorothiazide Benzatropine may increase the excretion rate of Chlorothiazide which could result in a lower serum level and potentially a reduction in efficacy. |
Chlorthalidone | Chlorthalidone Benzatropine may increase the excretion rate of Chlorthalidone which could result in a lower serum level and potentially a reduction in efficacy. |
Metolazone | Metolazone Benzatropine may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy. |
Isosorbide | Isosorbide Isosorbide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy. |
Secobarbital | Secobarbital Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Desipramine | Desipramine The metabolism of Desipramine can be decreased when combined with Benzatropine. |
Amitriptyline | Amitriptyline The metabolism of Benzatropine can be decreased when combined with Amitriptyline. |
Imipramine | Imipramine The metabolism of Imipramine can be decreased when combined with Benzatropine. |
Probenecid | Probenecid Benzatropine may decrease the excretion rate of Probenecid which could result in a higher serum level. |
Quinidine | Quinidine The metabolism of Quinidine can be decreased when combined with Benzatropine. |
Procainamide | Procainamide The metabolism of Procainamide can be decreased when combined with Benzatropine. |
Isoniazid | Isoniazid Benzatropine may decrease the excretion rate of Isoniazid which could result in a higher serum level. |
Pyrazinamide | Pyrazinamide Benzatropine may decrease the excretion rate of Pyrazinamide which could result in a higher serum level. |
Disopyramide | Disopyramide The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Disopyramide. |
Valproic Acid | Valproic Acid The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Valproic acid. |
Tamoxifen | Tamoxifen The metabolism of Benzatropine can be decreased when combined with Tamoxifen. |
Butabarbital | Butabarbital Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Liothyronine | Liothyronine Benzatropine may decrease the excretion rate of Liothyronine which could result in a higher serum level. |
Methimazole | Methimazole The metabolism of Methimazole can be decreased when combined with Benzatropine. |
Chlorpropamide | Chlorpropamide Benzatropine may decrease the excretion rate of Chlorpropamide which could result in a higher serum level. |
Glucagon Injection | Glucagon Injection Benzatropine may increase the gastrointestinal motility reducing activities of Glucagon. |
Tolbutamide | Tolbutamide Benzatropine may decrease the excretion rate of Tolbutamide which could result in a higher serum level. |
Tolazamide | Tolazamide Benzatropine may decrease the excretion rate of Tolazamide which could result in a higher serum level. |
Dextromethorphan | Dextromethorphan Dextromethorphan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Cyclobenzaprine | Cyclobenzaprine Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Niacin | Niacin The metabolism of Benzatropine can be decreased when combined with Niacin. |
Baclofen | Baclofen Baclofen may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Doxylamine | Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Cyproheptadine | Cyproheptadine Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Clemastine | Clemastine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Clemastine. |
Chlorpheniramine | Chlorpheniramine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Chlorpheniramine. |
Brompheniramine | Brompheniramine Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Meclizine | Meclizine Meclizine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Ethambutol | Ethambutol Benzatropine may decrease the excretion rate of Ethambutol which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide Benzatropine may increase the excretion rate of Methyclothiazide which could result in a lower serum level and potentially a reduction in efficacy. |
Hydrochlorothiazide | Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Dantrolene | Dantrolene Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Chlorzoxazone | Chlorzoxazone Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Carisoprodol | Carisoprodol Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Methocarbamol | Methocarbamol Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Pyridoxine | Pyridoxine Pyridoxine may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Folic Acid | Folic Acid Folic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Disulfiram | Disulfiram The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Disulfiram. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Propranolol. |
Pseudoephedrine | Pseudoephedrine Pseudoephedrine may decrease the sedative and stimulatory activities of Benzatropine. |
Nortriptyline | Nortriptyline The metabolism of Benzatropine can be decreased when combined with Nortriptyline. |
Spironolactone | Spironolactone Spironolactone may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy. |
Amphotericin B Injection | Amphotericin B Injection Amphotericin B may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Phytonadione | Phytonadione Benzatropine may decrease the excretion rate of Phylloquinone which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Amikacin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Nadolol | Nadolol Benzatropine may decrease the excretion rate of Nadolol which could result in a higher serum level. |
Butorphanol Injection | Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Benzatropine. |
Nalbuphine Injection | Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Benzatropine. |
Allopurinol | Allopurinol Benzatropine may decrease the excretion rate of Allopurinol which could result in a higher serum level. |
Oxytocin Injection | Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Benzatropine. |
Trimethobenzamide | Trimethobenzamide Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Flavoxate | Flavoxate Benzatropine may decrease the excretion rate of Flavoxate which could result in a higher serum level. |
Papaverine | Papaverine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Papaverine. |
Fluorouracil Injection | Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Fluorouracil. |
Colchicine | Colchicine Benzatropine may decrease the excretion rate of Colchicine which could result in a higher serum level. |
Cefaclor | Cefaclor Cefaclor may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Cefadroxil | Cefadroxil Cefadroxil may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection Cefazolin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Cephalexin | Cephalexin Cephalexin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection Cefoxitin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Dacarbazine | Dacarbazine Benzatropine may decrease the excretion rate of Dacarbazine which could result in a higher serum level. |
Acetazolamide | Acetazolamide Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Cefotaxime Injection | Cefotaxime Injection Cefotaxime may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Ketoconazole | Ketoconazole The metabolism of Benzatropine can be decreased when combined with Ketoconazole. |
Pyrantel | Pyrantel Pyrantel may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Thiotepa Injection | Thiotepa Injection The therapeutic efficacy of Benzatropine can be decreased when used in combination with Thiotepa. |
Isoxsuprine | Isoxsuprine The risk or severity of Tachycardia can be increased when Benzatropine is combined with Isoxsuprine. |
Vinblastine | Vinblastine The metabolism of Benzatropine can be decreased when combined with Vinblastine. |
Ethacrynic Acid | Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Colistimethate Injection | Colistimethate Injection Colistimethate may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Metoprolol | Metoprolol The metabolism of Metoprolol can be decreased when combined with Benzatropine. |
Hydroxyzine | Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Benzatropine. |
Thiothixene | Thiothixene The risk or severity of adverse effects can be increased when Thiothixene is combined with Benzatropine. |
Aspirin | Aspirin Acetylsalicylic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Salsalate | Salsalate Salsalate may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Alprazolam | Alprazolam Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Temazepam | Temazepam Temazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Triazolam | Triazolam Triazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Dicyclomine | Dicyclomine Benzatropine may decrease the excretion rate of Dicyclomine which could result in a higher serum level. |
Hyoscyamine | Hyoscyamine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Hyoscyamine. |
Propantheline | Propantheline Benzatropine may decrease the excretion rate of Propantheline which could result in a higher serum level. |
Trimethoprim | Trimethoprim Benzatropine may decrease the excretion rate of Trimethoprim which could result in a higher serum level. |
Diltiazem | Diltiazem The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Diltiazem. |
Nifedipine | Nifedipine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Nifedipine. |
Timolol | Timolol The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Timolol. |
Verapamil | Verapamil The metabolism of Verapamil can be decreased when combined with Benzatropine. |
Atenolol | Atenolol The metabolism of Atenolol can be decreased when combined with Benzatropine. |
Pindolol | Pindolol Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Pindolol. |
Cisplatin Injection | Cisplatin Injection Cisplatin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Diflunisal | Diflunisal Diflunisal may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Piroxicam | Piroxicam Piroxicam may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Bumetanide | Bumetanide Benzatropine may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy. |
Glipizide | Glipizide Benzatropine may decrease the excretion rate of Glipizide which could result in a higher serum level. |
Indapamide | Indapamide Benzatropine may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy. |
Amoxicillin | Amoxicillin Benzatropine may decrease the excretion rate of Amoxicillin which could result in a higher serum level. |
Oxacillin Injection | Oxacillin Injection Benzatropine may decrease the excretion rate of Oxacillin which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline Benzatropine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level. |
Pentamidine Injection | Pentamidine Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pentamidine. |
Ceftriaxone Injection | Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Labetalol | Labetalol The metabolism of Benzatropine can be decreased when combined with Labetalol. |
Auranofin | Auranofin Benzatropine may decrease the excretion rate of Auranofin which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Leuprolide. |
Gemfibrozil | Gemfibrozil Benzatropine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level. |
Guanabenz | Guanabenz The risk or severity of Tachycardia can be increased when Benzatropine is combined with Guanabenz. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Ceftazidime Injection | Ceftazidime Injection Ceftazidime may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Ketoprofen | Ketoprofen Ketoprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Cefotetan Injection | Cefotetan Injection Cefotetan may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Pimozide | Pimozide The risk or severity of adverse effects can be increased when Pimozide is combined with Benzatropine. |
Flurbiprofen | Flurbiprofen Flurbiprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Amiodarone | Amiodarone The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Benzatropine. |
Aztreonam Injection | Aztreonam Injection Benzatropine may decrease the excretion rate of Aztreonam which could result in a higher serum level. |
Buspirone | Buspirone The risk or severity of adverse effects can be increased when Buspirone is combined with Benzatropine. |
Lovastatin | Lovastatin The metabolism of Benzatropine can be decreased when combined with Lovastatin. |
Ciprofloxacin | Ciprofloxacin The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ciprofloxacin. |
Mesalamine | Mesalamine Mesalazine may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Diclofenac | Diclofenac Diclofenac may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Fluoxetine | Fluoxetine The serum concentration of Benzatropine can be increased when it is combined with Fluoxetine. |
Nimodipine | Nimodipine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Nimodipine. |
Clozapine | Clozapine The risk or severity of adverse effects can be increased when Clozapine is combined with Benzatropine. |
Estazolam | Estazolam Estazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Idarubicin | Idarubicin The metabolism of Idarubicin can be decreased when combined with Benzatropine. |
Ofloxacin | Ofloxacin The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ofloxacin. |
Didanosine | Didanosine Benzatropine may decrease the excretion rate of Didanosine which could result in a higher serum level. |
Pentostatin Injection | Pentostatin Injection Benzatropine may decrease the excretion rate of Pentostatin which could result in a higher serum level. |
Clarithromycin | Clarithromycin The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Clarithromycin. |
Etodolac | Etodolac Etodolac may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Felodipine | Felodipine The metabolism of Felodipine can be decreased when combined with Benzatropine. |
Fosinopril | Fosinopril Benzatropine may decrease the excretion rate of Fosinopril which could result in a higher serum level. |
Nabumetone | Nabumetone Nabumetone may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Simvastatin | Simvastatin The metabolism of Simvastatin can be decreased when combined with Benzatropine. |
Itraconazole | Itraconazole The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Itraconazole. |
Lisinopril | Lisinopril Benzatropine may decrease the excretion rate of Lisinopril which could result in a higher serum level. |
Oxaprozin | Oxaprozin Oxaprozin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Sotalol | Sotalol The metabolism of Sotalol can be decreased when combined with Benzatropine. |
Bisoprolol | Bisoprolol Benzatropine may decrease the excretion rate of Bisoprolol which could result in a higher serum level. |
Zolpidem | Zolpidem Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Doxazosin | Doxazosin The metabolism of Doxazosin can be decreased when combined with Benzatropine. |
Isradipine | Isradipine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Isradipine. |
Omeprazole | Omeprazole The metabolism of Benzatropine can be decreased when combined with Omeprazole. |
Cisapride | Cisapride The metabolism of Benzatropine can be decreased when combined with Cisapride. |
Gabapentin | Gabapentin Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Fluvastatin | Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Benzatropine. |
Venlafaxine | Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Benzatropine. |
Nizatidine | Nizatidine The therapeutic efficacy of Benzatropine can be decreased when used in combination with Nizatidine. |
Fluvoxamine | Fluvoxamine The metabolism of Benzatropine can be decreased when combined with Fluvoxamine. |
Nefazodone | Nefazodone Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Nefazodone. |
Lamotrigine | Lamotrigine Lamotrigine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Losartan | Losartan The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Losartan. |
Valacyclovir | Valacyclovir Valaciclovir may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Tramadol | Tramadol The risk or severity of adverse effects can be increased when Tramadol is combined with Benzatropine. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Benzatropine can be decreased when combined with Vinorelbine. |
Carboplatin Injection | Carboplatin Injection Carboplatin may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Moexipril | Moexipril The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Moexipril. |
Lansoprazole | Lansoprazole The metabolism of Benzatropine can be decreased when combined with Lansoprazole. |
Ifosfamide Injection | Ifosfamide Injection Benzatropine may decrease the excretion rate of Ifosfamide which could result in a higher serum level. |
Nicardipine | Nicardipine The metabolism of Benzatropine can be decreased when combined with Nicardipine. |
Bupropion | Bupropion The risk or severity of adverse effects can be increased when Bupropion is combined with Benzatropine. |
Ticlopidine | Ticlopidine The metabolism of Benzatropine can be decreased when combined with Ticlopidine. |
Saquinavir | Saquinavir The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Saquinavir. |
Metformin | Metformin Benzatropine may decrease the excretion rate of Metformin which could result in a higher serum level. |
Nisoldipine | Nisoldipine Benzatropine may decrease the excretion rate of Nisoldipine which could result in a higher serum level. |
Lamivudine | Lamivudine Benzatropine may decrease the excretion rate of Lamivudine which could result in a higher serum level. |
Riluzole | Riluzole Riluzole may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Acarbose | Acarbose Benzatropine may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Gemcitabine Injection | Gemcitabine Injection Benzatropine may decrease the excretion rate of Gemcitabine which could result in a higher serum level. |
Ritonavir | Ritonavir The metabolism of Benzatropine can be decreased when combined with Ritonavir. |
Cidofovir Injection | Cidofovir Injection Cidofovir may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Benzatropine may decrease the excretion rate of Meropenem which could result in a higher serum level. |
Clomipramine | Clomipramine The metabolism of Benzatropine can be decreased when combined with Clomipramine. |
Fosfomycin | Fosfomycin Benzatropine may decrease the excretion rate of Fosfomycin which could result in a higher serum level. |
Mirtazapine | Mirtazapine Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Topiramate | Topiramate The risk or severity of hyperthermia and oligohydrosis can be increased when Benzatropine is combined with Topiramate. |
Pramipexole | Pramipexole Benzatropine may decrease the excretion rate of Pramipexole which could result in a higher serum level. |
Donepezil | Donepezil The therapeutic efficacy of Benzatropine can be decreased when used in combination with Donepezil. |
Nelfinavir | Nelfinavir The metabolism of Benzatropine can be decreased when combined with Nelfinavir. |
Azithromycin | Azithromycin The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Azithromycin. |
Loratadine | Loratadine Benzatropine may increase the anticholinergic activities of Loratadine. |
Carvedilol | Carvedilol The metabolism of Carvedilol can be decreased when combined with Benzatropine. |
Nilutamide | Nilutamide Benzatropine may decrease the excretion rate of Nilutamide which could result in a higher serum level. |
Flutamide | Flutamide Benzatropine may decrease the excretion rate of Flutamide which could result in a higher serum level. |
Selegiline | Selegiline Selegiline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Bicalutamide | Bicalutamide The metabolism of Benzatropine can be decreased when combined with Bicalutamide. |
Sertraline | Sertraline Sertraline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Propafenone | Propafenone The metabolism of Benzatropine can be decreased when combined with Propafenone. |
Tamsulosin | Tamsulosin Benzatropine may decrease the excretion rate of Tamsulosin which could result in a higher serum level. |
Ropinirole | Ropinirole Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Quetiapine | Quetiapine The risk or severity of adverse effects can be increased when Quetiapine is combined with Benzatropine. |
Cefepime Injection | Cefepime Injection Cefepime may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Cefprozil | Cefprozil Cefprozil may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Cefpodoxime | Cefpodoxime Cefpodoxime may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Cetirizine | Cetirizine Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Cetirizine. |
Paroxetine | Paroxetine The metabolism of Benzatropine can be decreased when combined with Paroxetine. |
Tolcapone | Tolcapone Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Citalopram | Citalopram The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Citalopram. |
Capecitabine | Capecitabine Benzatropine may decrease the excretion rate of Capecitabine which could result in a higher serum level. |
Efavirenz | Efavirenz The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Efavirenz. |
Abacavir | Abacavir Benzatropine may decrease the excretion rate of Abacavir which could result in a higher serum level. |
Sildenafil | Sildenafil The metabolism of Benzatropine can be decreased when combined with Sildenafil. |
Celecoxib | Celecoxib The metabolism of Benzatropine can be decreased when combined with Celecoxib. |
Rosiglitazone | Rosiglitazone The metabolism of Benzatropine can be decreased when combined with Rosiglitazone. |
Tolterodine | Tolterodine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Tolterodine. |
Thalidomide | Thalidomide Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Oseltamivir | Oseltamivir Oseltamivir may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Balsalazide | Balsalazide Balsalazide may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Nateglinide | Nateglinide Benzatropine may decrease the excretion rate of Nateglinide which could result in a higher serum level. |
Galantamine | Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Benzatropine. |
Levetiracetam | Levetiracetam Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Rabeprazole | Rabeprazole Benzatropine may decrease the excretion rate of Rabeprazole which could result in a higher serum level. |
Terbinafine | Terbinafine The metabolism of Benzatropine can be decreased when combined with Terbinafine. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists